81 related articles for article (PubMed ID: 1397785)
1. Cyclosporin A treatment of young children with newly-diagnosed type 1 (insulin-dependent) diabetes mellitus. London Diabetes Study Group.
Jenner M; Bradish G; Stiller C; Atkison P
Diabetologia; 1992 Sep; 35(9):884-8. PubMed ID: 1397785
[TBL] [Abstract][Full Text] [Related]
2. Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus.
Snorgaard O; Hartling SG; Binder C
Diabetologia; 1990 Jan; 33(1):36-42. PubMed ID: 2303172
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of early cyclosporin therapy in juvenile IDDM.
De Filippo G; Carel JC; Boitard C; Bougnères PF
Diabetes; 1996 Jan; 45(1):101-4. PubMed ID: 8522052
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.
Faulds D; Goa KL; Benfield P
Drugs; 1993 Jun; 45(6):953-1040. PubMed ID: 7691501
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of erythropoietin is not responsible for the anaemia associated with cyclosporin treatment of insulin-dependent diabetes mellitus. Canadian-European Randomized Control Trial Group.
Nielsen OJ; Mandrup-Poulsen T; Nerup J
J Intern Med; 1993 Jun; 233(6):471-6. PubMed ID: 8501418
[TBL] [Abstract][Full Text] [Related]
6. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
Bougnères PF; Landais P; Boisson C; Carel JC; Frament N; Boitard C; Chaussain JL; Bach JF
Diabetes; 1990 Oct; 39(10):1264-72. PubMed ID: 2210078
[TBL] [Abstract][Full Text] [Related]
7. Interaction of bromocriptine and cyclosporine in insulin dependent diabetes mellitus: results from the Canadian open study.
Atkison PR; Mahon JL; Dupre J; Stiller CR; Jenner MR; Paul TL; Momah CI
J Autoimmun; 1990 Dec; 3(6):793-9. PubMed ID: 2088394
[TBL] [Abstract][Full Text] [Related]
8. [Use of cyclosporin A for remission induction in newly-detected insulin-dependent diabetes].
Zamaklar M; Lalić N; Djordjević P; Dragasević M; Vujosević S; Savić K; Kalimanovska V
Glas Srp Akad Nauka Med; 1994; (44):89-100. PubMed ID: 7590419
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group.
Pozzilli P; Visalli N; Boccuni ML; Baroni MG; Buzzetti R; Fioriti E; Signore A; Cavallo MG; Andreani D; Lucentini L
Diabet Med; 1994; 11(1):98-104. PubMed ID: 8181261
[TBL] [Abstract][Full Text] [Related]
10. IA-2 antibody-negative status predicts remission and recovery of C-peptide levels in type 1 diabetic patients treated with cyclosporin.
Christie MR; Mølvig J; Hawkes CJ; Carstensen B; Mandrup-Poulsen T;
Diabetes Care; 2002 Jul; 25(7):1192-7. PubMed ID: 12087018
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclosporine on insulin binding to erythrocytes in type 1 diabetes mellitus of recent onset.
Behme MT; Dupre J; Stiller CR
Clin Invest Med; 1988 Apr; 11(2):113-22. PubMed ID: 3293865
[TBL] [Abstract][Full Text] [Related]
12. Effect of FK506 on the development of diabetes in BB rats in comparison with that of cyclosporin.
Wakugami T; Islam MR; Higa S; Murakami K; Mimura G
Tohoku J Exp Med; 1993 Jan; 169(1):21-9. PubMed ID: 7692621
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression in autoimmune disease: the double-edged sword.
Jaworski MA; Jewell LD; Honore L; Mehta JG; Bayens-Simmonds J; McGuire-Clark P; Schouls JJ; Yap WY
Clin Invest Med; 1987 Sep; 10(5):488-95. PubMed ID: 3315371
[TBL] [Abstract][Full Text] [Related]
14. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
[TBL] [Abstract][Full Text] [Related]
15. Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin.
Assan R; Feutren G; Sirmai J; Laborie C; Boitard C; Vexiau P; Du Rostu H; Rodier M; Figoni M; Vague P
Diabetes; 1990 Jul; 39(7):768-74. PubMed ID: 2191883
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A in insulin-dependent diabetes mellitus of recent onset: a pilot study in children.
Lévy-Marchal C; Czernichow P
Horm Res; 1988; 29(5-6):177-84. PubMed ID: 3065205
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus.
Assan R; Feutren G; Debray-Sachs M; Quiniou-Debrie MC; Laborie C; Thomas G; Chatenoud L; Bach JF
Lancet; 1985 Jan; 1(8420):67-71. PubMed ID: 2857024
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects.
Martin S; Schernthaner G; Nerup J; Gries FA; Koivisto VA; Dupré J; Standl E; Hamet P; McArthur R; Tan MH
Diabetologia; 1991 Jun; 34(6):429-34. PubMed ID: 1884902
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.
Feutren G; Papoz L; Assan R; Vialettes B; Karsenty G; Vexiau P; Du Rostu H; Rodier M; Sirmai J; Lallemand A
Lancet; 1986 Jul; 2(8499):119-24. PubMed ID: 2873396
[TBL] [Abstract][Full Text] [Related]
20. Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term follow-up.
Gu Y; Gong C; Peng X; Wei L; Su C; Qin M; Wang X; Li F
Chin Med J (Engl); 2014; 127(14):2618-22. PubMed ID: 25043077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
